nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Anagrelide—hematologic cancer	0.0564	0.111	CbGbCtD
Imiquimod—CYP1A2—Carmustine—hematologic cancer	0.0296	0.0585	CbGbCtD
Imiquimod—CYP1A2—Methoxsalen—hematologic cancer	0.0252	0.0497	CbGbCtD
Imiquimod—CYP1A2—Bortezomib—hematologic cancer	0.024	0.0473	CbGbCtD
Imiquimod—CYP1A2—Daunorubicin—hematologic cancer	0.0229	0.0452	CbGbCtD
Imiquimod—CYP1A2—Alitretinoin—hematologic cancer	0.0225	0.0443	CbGbCtD
Imiquimod—CYP1A2—Thalidomide—hematologic cancer	0.0209	0.0412	CbGbCtD
Imiquimod—CYP3A4—Bexarotene—hematologic cancer	0.0205	0.0404	CbGbCtD
Imiquimod—CYP3A4—Lomustine—hematologic cancer	0.0191	0.0376	CbGbCtD
Imiquimod—CYP3A4—Busulfan—hematologic cancer	0.0191	0.0376	CbGbCtD
Imiquimod—CYP1A2—Dacarbazine—hematologic cancer	0.018	0.0354	CbGbCtD
Imiquimod—CYP1A2—Imatinib—hematologic cancer	0.0176	0.0346	CbGbCtD
Imiquimod—CYP3A4—Thiotepa—hematologic cancer	0.017	0.0335	CbGbCtD
Imiquimod—CYP1A2—Dasatinib—hematologic cancer	0.0141	0.0278	CbGbCtD
Imiquimod—CYP3A4—Methoxsalen—hematologic cancer	0.0132	0.026	CbGbCtD
Imiquimod—CYP3A4—Bortezomib—hematologic cancer	0.0126	0.0248	CbGbCtD
Imiquimod—TLR8—hematopoietic system—hematologic cancer	0.0123	0.162	CbGeAlD
Imiquimod—CYP3A4—Daunorubicin—hematologic cancer	0.012	0.0237	CbGbCtD
Imiquimod—CYP3A4—Cytarabine—hematologic cancer	0.0106	0.0209	CbGbCtD
Imiquimod—CYP3A4—Teniposide—hematologic cancer	0.0104	0.0206	CbGbCtD
Imiquimod—CYP3A4—Ifosfamide—hematologic cancer	0.00963	0.019	CbGbCtD
Imiquimod—CYP3A4—Imatinib—hematologic cancer	0.0092	0.0181	CbGbCtD
Imiquimod—CYP1A2—Etoposide—hematologic cancer	0.00879	0.0173	CbGbCtD
Imiquimod—CYP3A4—Ruxolitinib—hematologic cancer	0.00867	0.0171	CbGbCtD
Imiquimod—CYP3A4—Nilotinib—hematologic cancer	0.00836	0.0165	CbGbCtD
Imiquimod—CYP3A4—Vinorelbine—hematologic cancer	0.00829	0.0164	CbGbCtD
Imiquimod—TLR8—blood—hematologic cancer	0.00816	0.108	CbGeAlD
Imiquimod—TLR8—bone marrow—hematologic cancer	0.0079	0.104	CbGeAlD
Imiquimod—TLR7—hematopoietic system—hematologic cancer	0.00777	0.102	CbGeAlD
Imiquimod—CYP3A4—Triamcinolone—hematologic cancer	0.00758	0.015	CbGbCtD
Imiquimod—CYP3A4—Dasatinib—hematologic cancer	0.00739	0.0146	CbGbCtD
Imiquimod—CYP3A4—Mitoxantrone—hematologic cancer	0.0073	0.0144	CbGbCtD
Imiquimod—TLR8—lung—hematologic cancer	0.00715	0.0942	CbGeAlD
Imiquimod—CYP3A4—Betamethasone—hematologic cancer	0.00651	0.0128	CbGbCtD
Imiquimod—CYP3A4—Prednisolone—hematologic cancer	0.00642	0.0127	CbGbCtD
Imiquimod—CYP3A4—Prednisone—hematologic cancer	0.00606	0.012	CbGbCtD
Imiquimod—TLR7—gonad—hematologic cancer	0.0059	0.0778	CbGeAlD
Imiquimod—CYP3A4—Irinotecan—hematologic cancer	0.00575	0.0113	CbGbCtD
Imiquimod—TLR7—blood—hematologic cancer	0.00515	0.0678	CbGeAlD
Imiquimod—CYP3A4—Vinblastine—hematologic cancer	0.00511	0.0101	CbGbCtD
Imiquimod—CYP3A4—Vincristine—hematologic cancer	0.00502	0.00991	CbGbCtD
Imiquimod—TLR8—lymph node—hematologic cancer	0.00489	0.0645	CbGeAlD
Imiquimod—CYP3A4—Etoposide—hematologic cancer	0.0046	0.00908	CbGbCtD
Imiquimod—TLR7—lung—hematologic cancer	0.00451	0.0594	CbGeAlD
Imiquimod—TLR7—testis—hematologic cancer	0.00426	0.0561	CbGeAlD
Imiquimod—CYP3A4—Dexamethasone—hematologic cancer	0.00379	0.00746	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—hematologic cancer	0.00314	0.00619	CbGbCtD
Imiquimod—TLR7—lymph node—hematologic cancer	0.00308	0.0406	CbGeAlD
Imiquimod—CYP1A2—hematopoietic system—hematologic cancer	0.0014	0.0184	CbGeAlD
Imiquimod—CYP3A4—hematopoietic system—hematologic cancer	0.00101	0.0133	CbGeAlD
Imiquimod—CYP1A2—blood—hematologic cancer	0.000927	0.0122	CbGeAlD
Imiquimod—CYP1A2—lung—hematologic cancer	0.000812	0.0107	CbGeAlD
Imiquimod—CYP3A4—blood—hematologic cancer	0.000671	0.00884	CbGeAlD
Imiquimod—TLR8—Innate Immune System—PIK3CA—hematologic cancer	4.31e-05	0.000362	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BCL2—hematologic cancer	4.3e-05	0.000361	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—SRC—hematologic cancer	4.29e-05	0.00036	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	4.28e-05	0.000359	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	4.27e-05	0.000358	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNG—hematologic cancer	4.26e-05	0.000357	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ICAM1—hematologic cancer	4.24e-05	0.000356	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MDM2—hematologic cancer	4.23e-05	0.000355	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	4.22e-05	0.000354	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NFKBIA—hematologic cancer	4.21e-05	0.000353	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BAD—hematologic cancer	4.21e-05	0.000353	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	4.2e-05	0.000352	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NRAS—hematologic cancer	4.13e-05	0.000347	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—MTR—hematologic cancer	4.12e-05	0.000346	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MTOR—hematologic cancer	4.12e-05	0.000346	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PIK3CB—hematologic cancer	4.12e-05	0.000346	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD4—hematologic cancer	4.11e-05	0.000345	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD80—hematologic cancer	4.08e-05	0.000343	CbGpPWpGaD
Imiquimod—TLR7—Immune System—KIT—hematologic cancer	4.07e-05	0.000342	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTPN11—hematologic cancer	4e-05	0.000336	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HRAS—hematologic cancer	3.99e-05	0.000335	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK3—hematologic cancer	3.96e-05	0.000332	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	3.92e-05	0.000329	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	3.9e-05	0.000328	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FOS—hematologic cancer	3.88e-05	0.000326	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CREB1—hematologic cancer	3.88e-05	0.000325	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDKN1B—hematologic cancer	3.87e-05	0.000324	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	3.85e-05	0.000323	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	3.83e-05	0.000322	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	3.83e-05	0.000322	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—hematologic cancer	3.82e-05	0.00032	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—hematologic cancer	3.8e-05	0.000319	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP8—hematologic cancer	3.79e-05	0.000318	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6R—hematologic cancer	3.78e-05	0.000317	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2—hematologic cancer	3.78e-05	0.000317	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CREBBP—hematologic cancer	3.78e-05	0.000317	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	3.76e-05	0.000316	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	3.75e-05	0.000315	CbGpPWpGaD
Imiquimod—TLR8—Immune System—JUN—hematologic cancer	3.68e-05	0.000309	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	3.67e-05	0.000308	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	3.65e-05	0.000306	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	3.62e-05	0.000304	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAP2K1—hematologic cancer	3.6e-05	0.000303	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CD—hematologic cancer	3.58e-05	0.000301	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDKN1A—hematologic cancer	3.57e-05	0.000299	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTEN—hematologic cancer	3.56e-05	0.000299	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—KRAS—hematologic cancer	3.56e-05	0.000298	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	3.54e-05	0.000297	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—hematologic cancer	3.52e-05	0.000296	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK8—hematologic cancer	3.48e-05	0.000292	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FGF2—hematologic cancer	3.43e-05	0.000288	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EP300—hematologic cancer	3.39e-05	0.000285	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3R1—hematologic cancer	3.38e-05	0.000284	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	3.36e-05	0.000282	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	3.36e-05	0.000282	CbGpPWpGaD
Imiquimod—TLR8—Immune System—SRC—hematologic cancer	3.3e-05	0.000277	CbGpPWpGaD
Imiquimod—TLR7—Immune System—JAK2—hematologic cancer	3.29e-05	0.000276	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	3.27e-05	0.000275	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	3.27e-05	0.000275	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PIK3CA—hematologic cancer	3.27e-05	0.000274	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—hematologic cancer	3.26e-05	0.000273	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.24e-05	0.000272	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNG—hematologic cancer	3.23e-05	0.000271	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MDM2—hematologic cancer	3.21e-05	0.000269	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	3.19e-05	0.000267	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—hematologic cancer	3.18e-05	0.000267	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.18e-05	0.000267	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NRAS—hematologic cancer	3.18e-05	0.000266	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	3.15e-05	0.000264	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CB—hematologic cancer	3.12e-05	0.000262	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MTOR—hematologic cancer	3.12e-05	0.000262	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD4—hematologic cancer	3.12e-05	0.000261	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK3—hematologic cancer	3.04e-05	0.000255	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.03e-05	0.000254	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HRAS—hematologic cancer	3.02e-05	0.000254	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	3.01e-05	0.000253	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	2.93e-05	0.000246	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1B—hematologic cancer	2.93e-05	0.000246	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	2.93e-05	0.000245	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—hematologic cancer	2.89e-05	0.000243	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—hematologic cancer	2.88e-05	0.000242	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—hematologic cancer	2.87e-05	0.000241	CbGpPWpGaD
Imiquimod—TLR7—Immune System—JUN—hematologic cancer	2.79e-05	0.000234	CbGpPWpGaD
Imiquimod—TLR8—Immune System—KRAS—hematologic cancer	2.73e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	2.73e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	2.73e-05	0.000229	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	2.72e-05	0.000228	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	2.71e-05	0.000227	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDKN1A—hematologic cancer	2.7e-05	0.000227	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—hematologic cancer	2.7e-05	0.000226	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	2.68e-05	0.000225	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—hematologic cancer	2.67e-05	0.000224	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK8—hematologic cancer	2.64e-05	0.000221	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EP300—hematologic cancer	2.57e-05	0.000216	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PIK3CA—hematologic cancer	2.51e-05	0.000211	CbGpPWpGaD
Imiquimod—TLR7—Immune System—SRC—hematologic cancer	2.5e-05	0.00021	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	2.5e-05	0.00021	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	2.46e-05	0.000207	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	2.46e-05	0.000206	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—hematologic cancer	2.41e-05	0.000202	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NRAS—hematologic cancer	2.41e-05	0.000202	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—hematologic cancer	2.32e-05	0.000195	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK3—hematologic cancer	2.3e-05	0.000193	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	2.3e-05	0.000193	CbGpPWpGaD
Imiquimod—Infection—Prednisone—hematologic cancer	2.25e-05	7.55e-05	CcSEcCtD
Imiquimod—Mediastinal disorder—Epirubicin—hematologic cancer	2.24e-05	7.53e-05	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.24e-05	7.53e-05	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.24e-05	7.53e-05	CcSEcCtD
Imiquimod—Back pain—Methotrexate—hematologic cancer	2.24e-05	7.52e-05	CcSEcCtD
Imiquimod—Fatigue—Dexamethasone—hematologic cancer	2.24e-05	7.52e-05	CcSEcCtD
Imiquimod—Fatigue—Betamethasone—hematologic cancer	2.24e-05	7.52e-05	CcSEcCtD
Imiquimod—Chills—Epirubicin—hematologic cancer	2.23e-05	7.5e-05	CcSEcCtD
Imiquimod—Pruritus—Etoposide—hematologic cancer	2.23e-05	7.5e-05	CcSEcCtD
Imiquimod—Shock—Prednisone—hematologic cancer	2.23e-05	7.47e-05	CcSEcCtD
Imiquimod—Arrhythmia—Epirubicin—hematologic cancer	2.22e-05	7.47e-05	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6—hematologic cancer	2.22e-05	0.000187	CbGpPWpGaD
Imiquimod—Pain—Betamethasone—hematologic cancer	2.22e-05	7.46e-05	CcSEcCtD
Imiquimod—Pain—Dexamethasone—hematologic cancer	2.22e-05	7.46e-05	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—hematologic cancer	2.22e-05	7.45e-05	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—hematologic cancer	2.22e-05	7.45e-05	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—hematologic cancer	2.21e-05	7.41e-05	CcSEcCtD
Imiquimod—Alopecia—Epirubicin—hematologic cancer	2.2e-05	7.39e-05	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—hematologic cancer	2.2e-05	7.38e-05	CcSEcCtD
Imiquimod—Nausea—Gemcitabine—hematologic cancer	2.2e-05	7.37e-05	CcSEcCtD
Imiquimod—Vomiting—Cisplatin—hematologic cancer	2.19e-05	7.35e-05	CcSEcCtD
Imiquimod—Hyperhidrosis—Prednisone—hematologic cancer	2.19e-05	7.34e-05	CcSEcCtD
Imiquimod—Mental disorder—Epirubicin—hematologic cancer	2.18e-05	7.32e-05	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—hematologic cancer	2.18e-05	7.31e-05	CcSEcCtD
Imiquimod—Rash—Cisplatin—hematologic cancer	2.17e-05	7.29e-05	CcSEcCtD
Imiquimod—Dermatitis—Cisplatin—hematologic cancer	2.17e-05	7.29e-05	CcSEcCtD
Imiquimod—Erythema—Epirubicin—hematologic cancer	2.17e-05	7.28e-05	CcSEcCtD
Imiquimod—Malnutrition—Epirubicin—hematologic cancer	2.17e-05	7.28e-05	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—hematologic cancer	2.16e-05	7.25e-05	CcSEcCtD
Imiquimod—Anorexia—Prednisone—hematologic cancer	2.16e-05	7.24e-05	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—hematologic cancer	2.15e-05	7.23e-05	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—hematologic cancer	2.15e-05	7.22e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	2.15e-05	0.00018	CbGpPWpGaD
Imiquimod—Tinnitus—Doxorubicin—hematologic cancer	2.15e-05	7.21e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Dexamethasone—hematologic cancer	2.14e-05	7.19e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Betamethasone—hematologic cancer	2.14e-05	7.19e-05	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—hematologic cancer	2.14e-05	7.18e-05	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.12e-05	7.13e-05	CcSEcCtD
Imiquimod—Gastrointestinal pain—Betamethasone—hematologic cancer	2.12e-05	7.13e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Triamcinolone—hematologic cancer	2.11e-05	7.08e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.1e-05	0.000176	CbGpPWpGaD
Imiquimod—Back pain—Epirubicin—hematologic cancer	2.1e-05	7.04e-05	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—hematologic cancer	2.09e-05	7.02e-05	CcSEcCtD
Imiquimod—Malaise—Methotrexate—hematologic cancer	2.09e-05	7.01e-05	CcSEcCtD
Imiquimod—Dizziness—Etoposide—hematologic cancer	2.09e-05	7.01e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—PHYH—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GMPS—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FTCD—hematologic cancer	2.08e-05	0.000175	CbGpPWpGaD
Imiquimod—Immune system disorder—Doxorubicin—hematologic cancer	2.08e-05	6.99e-05	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—hematologic cancer	2.08e-05	6.97e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—KRAS—hematologic cancer	2.07e-05	0.000174	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.07e-05	0.000174	CbGpPWpGaD
Imiquimod—Chills—Doxorubicin—hematologic cancer	2.07e-05	6.94e-05	CcSEcCtD
Imiquimod—Urticaria—Betamethasone—hematologic cancer	2.06e-05	6.93e-05	CcSEcCtD
Imiquimod—Urticaria—Dexamethasone—hematologic cancer	2.06e-05	6.93e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	2.06e-05	0.000173	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.06e-05	6.92e-05	CcSEcCtD
Imiquimod—Dizziness—Prednisolone—hematologic cancer	2.06e-05	6.91e-05	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—hematologic cancer	2.06e-05	6.91e-05	CcSEcCtD
Imiquimod—Asthenia—Triamcinolone—hematologic cancer	2.05e-05	6.9e-05	CcSEcCtD
Imiquimod—Abdominal pain—Betamethasone—hematologic cancer	2.05e-05	6.89e-05	CcSEcCtD
Imiquimod—Body temperature increased—Dexamethasone—hematologic cancer	2.05e-05	6.89e-05	CcSEcCtD
Imiquimod—Abdominal pain—Dexamethasone—hematologic cancer	2.05e-05	6.89e-05	CcSEcCtD
Imiquimod—Body temperature increased—Betamethasone—hematologic cancer	2.05e-05	6.89e-05	CcSEcCtD
Imiquimod—TLR8—Immune System—AKT1—hematologic cancer	2.05e-05	0.000172	CbGpPWpGaD
Imiquimod—Nausea—Cisplatin—hematologic cancer	2.05e-05	6.87e-05	CcSEcCtD
Imiquimod—Insomnia—Prednisone—hematologic cancer	2.05e-05	6.87e-05	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—hematologic cancer	2.04e-05	6.84e-05	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—hematologic cancer	2.03e-05	6.82e-05	CcSEcCtD
Imiquimod—Pruritus—Triamcinolone—hematologic cancer	2.03e-05	6.8e-05	CcSEcCtD
Imiquimod—Cough—Methotrexate—hematologic cancer	2.02e-05	6.79e-05	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—hematologic cancer	2.02e-05	6.78e-05	CcSEcCtD
Imiquimod—Ill-defined disorder—Epirubicin—hematologic cancer	2.01e-05	6.75e-05	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—hematologic cancer	2.01e-05	6.74e-05	CcSEcCtD
Imiquimod—Vomiting—Etoposide—hematologic cancer	2.01e-05	6.74e-05	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—hematologic cancer	2.01e-05	6.73e-05	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—hematologic cancer	2.01e-05	6.73e-05	CcSEcCtD
Imiquimod—Agitation—Epirubicin—hematologic cancer	1.99e-05	6.69e-05	CcSEcCtD
Imiquimod—Dyspepsia—Prednisone—hematologic cancer	1.99e-05	6.69e-05	CcSEcCtD
Imiquimod—Rash—Etoposide—hematologic cancer	1.99e-05	6.68e-05	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—hematologic cancer	1.99e-05	6.68e-05	CcSEcCtD
Imiquimod—Headache—Etoposide—hematologic cancer	1.98e-05	6.64e-05	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—hematologic cancer	1.97e-05	6.62e-05	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—hematologic cancer	1.97e-05	6.62e-05	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—hematologic cancer	1.97e-05	6.62e-05	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—hematologic cancer	1.97e-05	6.6e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.96e-05	0.000165	CbGpPWpGaD
Imiquimod—Rash—Prednisolone—hematologic cancer	1.96e-05	6.59e-05	CcSEcCtD
Imiquimod—Dermatitis—Prednisolone—hematologic cancer	1.96e-05	6.58e-05	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.96e-05	6.58e-05	CcSEcCtD
Imiquimod—Malaise—Epirubicin—hematologic cancer	1.95e-05	6.56e-05	CcSEcCtD
Imiquimod—Fatigue—Prednisone—hematologic cancer	1.95e-05	6.55e-05	CcSEcCtD
Imiquimod—Headache—Prednisolone—hematologic cancer	1.95e-05	6.55e-05	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—hematologic cancer	1.95e-05	6.54e-05	CcSEcCtD
Imiquimod—Syncope—Epirubicin—hematologic cancer	1.94e-05	6.53e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.94e-05	0.000163	CbGpPWpGaD
Imiquimod—Back pain—Doxorubicin—hematologic cancer	1.94e-05	6.51e-05	CcSEcCtD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	1.93e-05	0.000162	CbGpPWpGaD
Imiquimod—Palpitations—Epirubicin—hematologic cancer	1.92e-05	6.43e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.91e-05	0.00016	CbGpPWpGaD
Imiquimod—Loss of consciousness—Epirubicin—hematologic cancer	1.91e-05	6.4e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—PIK3CA—hematologic cancer	1.9e-05	0.00016	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	1.9e-05	0.00016	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.9e-05	0.00016	CbGpPWpGaD
Imiquimod—Dizziness—Triamcinolone—hematologic cancer	1.89e-05	6.36e-05	CcSEcCtD
Imiquimod—Cough—Epirubicin—hematologic cancer	1.89e-05	6.35e-05	CcSEcCtD
Imiquimod—Convulsion—Epirubicin—hematologic cancer	1.88e-05	6.31e-05	CcSEcCtD
Imiquimod—Infection—Methotrexate—hematologic cancer	1.88e-05	6.31e-05	CcSEcCtD
Imiquimod—Nausea—Etoposide—hematologic cancer	1.87e-05	6.29e-05	CcSEcCtD
Imiquimod—Hypertension—Epirubicin—hematologic cancer	1.87e-05	6.28e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisone—hematologic cancer	1.86e-05	6.26e-05	CcSEcCtD
Imiquimod—Asthenia—Betamethasone—hematologic cancer	1.86e-05	6.26e-05	CcSEcCtD
Imiquimod—Asthenia—Dexamethasone—hematologic cancer	1.86e-05	6.26e-05	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—hematologic cancer	1.86e-05	6.25e-05	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—hematologic cancer	1.85e-05	6.22e-05	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—hematologic cancer	1.85e-05	6.21e-05	CcSEcCtD
Imiquimod—Nausea—Prednisolone—hematologic cancer	1.85e-05	6.21e-05	CcSEcCtD
Imiquimod—Myalgia—Epirubicin—hematologic cancer	1.85e-05	6.2e-05	CcSEcCtD
Imiquimod—Arthralgia—Epirubicin—hematologic cancer	1.85e-05	6.2e-05	CcSEcCtD
Imiquimod—Chest pain—Epirubicin—hematologic cancer	1.85e-05	6.2e-05	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—hematologic cancer	1.84e-05	6.19e-05	CcSEcCtD
Imiquimod—Anxiety—Epirubicin—hematologic cancer	1.84e-05	6.17e-05	CcSEcCtD
Imiquimod—Pruritus—Betamethasone—hematologic cancer	1.84e-05	6.17e-05	CcSEcCtD
Imiquimod—Pruritus—Dexamethasone—hematologic cancer	1.84e-05	6.17e-05	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—hematologic cancer	1.84e-05	6.17e-05	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.83e-05	6.15e-05	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—hematologic cancer	1.83e-05	6.14e-05	CcSEcCtD
Imiquimod—Discomfort—Epirubicin—hematologic cancer	1.82e-05	6.12e-05	CcSEcCtD
Imiquimod—Vomiting—Triamcinolone—hematologic cancer	1.82e-05	6.11e-05	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—hematologic cancer	1.81e-05	6.07e-05	CcSEcCtD
Imiquimod—Rash—Triamcinolone—hematologic cancer	1.8e-05	6.06e-05	CcSEcCtD
Imiquimod—Dry mouth—Epirubicin—hematologic cancer	1.8e-05	6.06e-05	CcSEcCtD
Imiquimod—Dermatitis—Triamcinolone—hematologic cancer	1.8e-05	6.05e-05	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—hematologic cancer	1.8e-05	6.05e-05	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—hematologic cancer	1.8e-05	6.04e-05	CcSEcCtD
Imiquimod—Urticaria—Prednisone—hematologic cancer	1.8e-05	6.03e-05	CcSEcCtD
Imiquimod—Headache—Triamcinolone—hematologic cancer	1.79e-05	6.02e-05	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—hematologic cancer	1.79e-05	6e-05	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—hematologic cancer	1.79e-05	6e-05	CcSEcCtD
Imiquimod—Diarrhoea—Dexamethasone—hematologic cancer	1.78e-05	5.97e-05	CcSEcCtD
Imiquimod—Diarrhoea—Betamethasone—hematologic cancer	1.78e-05	5.97e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.78e-05	0.000149	CbGpPWpGaD
Imiquimod—Palpitations—Doxorubicin—hematologic cancer	1.77e-05	5.95e-05	CcSEcCtD
Imiquimod—Oedema—Epirubicin—hematologic cancer	1.77e-05	5.94e-05	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—hematologic cancer	1.76e-05	5.92e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—HRAS—hematologic cancer	1.76e-05	0.000148	CbGpPWpGaD
Imiquimod—Infection—Epirubicin—hematologic cancer	1.76e-05	5.9e-05	CcSEcCtD
Imiquimod—Cough—Doxorubicin—hematologic cancer	1.75e-05	5.88e-05	CcSEcCtD
Imiquimod—Shock—Epirubicin—hematologic cancer	1.74e-05	5.84e-05	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—hematologic cancer	1.74e-05	5.83e-05	CcSEcCtD
Imiquimod—Nervous system disorder—Epirubicin—hematologic cancer	1.73e-05	5.83e-05	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—hematologic cancer	1.73e-05	5.81e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.73e-05	0.000145	CbGpPWpGaD
Imiquimod—Tachycardia—Epirubicin—hematologic cancer	1.73e-05	5.8e-05	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.72e-05	5.78e-05	CcSEcCtD
Imiquimod—Skin disorder—Epirubicin—hematologic cancer	1.72e-05	5.77e-05	CcSEcCtD
Imiquimod—Dizziness—Betamethasone—hematologic cancer	1.72e-05	5.77e-05	CcSEcCtD
Imiquimod—Dizziness—Dexamethasone—hematologic cancer	1.72e-05	5.77e-05	CcSEcCtD
Imiquimod—Hyperhidrosis—Epirubicin—hematologic cancer	1.71e-05	5.74e-05	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—hematologic cancer	1.71e-05	5.74e-05	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—hematologic cancer	1.71e-05	5.73e-05	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—hematologic cancer	1.71e-05	5.73e-05	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—hematologic cancer	1.71e-05	5.73e-05	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—hematologic cancer	1.7e-05	5.71e-05	CcSEcCtD
Imiquimod—Nausea—Triamcinolone—hematologic cancer	1.7e-05	5.71e-05	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—hematologic cancer	1.7e-05	5.7e-05	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.7e-05	5.69e-05	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—hematologic cancer	1.69e-05	5.66e-05	CcSEcCtD
Imiquimod—Anorexia—Epirubicin—hematologic cancer	1.69e-05	5.66e-05	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—hematologic cancer	1.69e-05	5.66e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—IL6—hematologic cancer	1.68e-05	0.000141	CbGpPWpGaD
Imiquimod—Somnolence—Methotrexate—hematologic cancer	1.68e-05	5.64e-05	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—hematologic cancer	1.67e-05	5.61e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisone—hematologic cancer	1.67e-05	5.6e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—ASNS—hematologic cancer	1.67e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.67e-05	0.00014	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DCK—hematologic cancer	1.67e-05	0.00014	CbGpPWpGaD
Imiquimod—Dyspepsia—Methotrexate—hematologic cancer	1.66e-05	5.59e-05	CcSEcCtD
Imiquimod—Vomiting—Dexamethasone—hematologic cancer	1.65e-05	5.54e-05	CcSEcCtD
Imiquimod—Vomiting—Betamethasone—hematologic cancer	1.65e-05	5.54e-05	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—hematologic cancer	1.64e-05	5.52e-05	CcSEcCtD
Imiquimod—Rash—Betamethasone—hematologic cancer	1.64e-05	5.5e-05	CcSEcCtD
Imiquimod—Rash—Dexamethasone—hematologic cancer	1.64e-05	5.5e-05	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—hematologic cancer	1.64e-05	5.5e-05	CcSEcCtD
Imiquimod—Dermatitis—Betamethasone—hematologic cancer	1.64e-05	5.49e-05	CcSEcCtD
Imiquimod—Dermatitis—Dexamethasone—hematologic cancer	1.64e-05	5.49e-05	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.63e-05	5.48e-05	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—hematologic cancer	1.63e-05	5.47e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.63e-05	0.000137	CbGpPWpGaD
Imiquimod—Headache—Betamethasone—hematologic cancer	1.63e-05	5.46e-05	CcSEcCtD
Imiquimod—Headache—Dexamethasone—hematologic cancer	1.63e-05	5.46e-05	CcSEcCtD
Imiquimod—Infection—Doxorubicin—hematologic cancer	1.63e-05	5.46e-05	CcSEcCtD
Imiquimod—Asthenia—Prednisone—hematologic cancer	1.62e-05	5.45e-05	CcSEcCtD
Imiquimod—Pain—Methotrexate—hematologic cancer	1.62e-05	5.43e-05	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.61e-05	5.41e-05	CcSEcCtD
Imiquimod—Shock—Doxorubicin—hematologic cancer	1.61e-05	5.41e-05	CcSEcCtD
Imiquimod—CYP3A4—Metabolism—PHYH—hematologic cancer	1.61e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GMPS—hematologic cancer	1.61e-05	0.000135	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FTCD—hematologic cancer	1.61e-05	0.000135	CbGpPWpGaD
Imiquimod—Nervous system disorder—Doxorubicin—hematologic cancer	1.61e-05	5.39e-05	CcSEcCtD
Imiquimod—Pruritus—Prednisone—hematologic cancer	1.6e-05	5.37e-05	CcSEcCtD
Imiquimod—Insomnia—Epirubicin—hematologic cancer	1.6e-05	5.37e-05	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—hematologic cancer	1.6e-05	5.36e-05	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—hematologic cancer	1.59e-05	5.34e-05	CcSEcCtD
Imiquimod—Paraesthesia—Epirubicin—hematologic cancer	1.59e-05	5.33e-05	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—hematologic cancer	1.58e-05	5.31e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—HDC—hematologic cancer	1.58e-05	0.000133	CbGpPWpGaD
Imiquimod—Dyspnoea—Epirubicin—hematologic cancer	1.58e-05	5.3e-05	CcSEcCtD
Imiquimod—Somnolence—Epirubicin—hematologic cancer	1.57e-05	5.28e-05	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—hematologic cancer	1.56e-05	5.24e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—hematologic cancer	1.56e-05	5.23e-05	CcSEcCtD
Imiquimod—Dyspepsia—Epirubicin—hematologic cancer	1.56e-05	5.23e-05	CcSEcCtD
Imiquimod—TLR7—Immune System—AKT1—hematologic cancer	1.55e-05	0.00013	CbGpPWpGaD
Imiquimod—Diarrhoea—Prednisone—hematologic cancer	1.55e-05	5.2e-05	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—hematologic cancer	1.55e-05	5.19e-05	CcSEcCtD
Imiquimod—Nausea—Betamethasone—hematologic cancer	1.54e-05	5.18e-05	CcSEcCtD
Imiquimod—Nausea—Dexamethasone—hematologic cancer	1.54e-05	5.18e-05	CcSEcCtD
Imiquimod—Decreased appetite—Epirubicin—hematologic cancer	1.54e-05	5.16e-05	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.53e-05	5.13e-05	CcSEcCtD
Imiquimod—Fatigue—Epirubicin—hematologic cancer	1.53e-05	5.12e-05	CcSEcCtD
Imiquimod—Pain—Epirubicin—hematologic cancer	1.51e-05	5.08e-05	CcSEcCtD
Imiquimod—Urticaria—Methotrexate—hematologic cancer	1.5e-05	5.04e-05	CcSEcCtD
Imiquimod—Dizziness—Prednisone—hematologic cancer	1.5e-05	5.02e-05	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—hematologic cancer	1.49e-05	5.02e-05	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—hematologic cancer	1.49e-05	5.02e-05	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.49e-05	5.01e-05	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—hematologic cancer	1.48e-05	4.97e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.47e-05	0.000124	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.47e-05	0.000123	CbGpPWpGaD
Imiquimod—Paraesthesia—Doxorubicin—hematologic cancer	1.47e-05	4.94e-05	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—hematologic cancer	1.46e-05	4.9e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Epirubicin—hematologic cancer	1.46e-05	4.89e-05	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—hematologic cancer	1.46e-05	4.89e-05	CcSEcCtD
Imiquimod—Gastrointestinal pain—Epirubicin—hematologic cancer	1.45e-05	4.86e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—CDA—hematologic cancer	1.44e-05	0.000121	CbGpPWpGaD
Imiquimod—Dyspepsia—Doxorubicin—hematologic cancer	1.44e-05	4.84e-05	CcSEcCtD
Imiquimod—Vomiting—Prednisone—hematologic cancer	1.44e-05	4.83e-05	CcSEcCtD
Imiquimod—Rash—Prednisone—hematologic cancer	1.43e-05	4.79e-05	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—hematologic cancer	1.42e-05	4.78e-05	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—hematologic cancer	1.42e-05	4.78e-05	CcSEcCtD
Imiquimod—Headache—Prednisone—hematologic cancer	1.42e-05	4.76e-05	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.41e-05	4.74e-05	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—hematologic cancer	1.41e-05	4.74e-05	CcSEcCtD
Imiquimod—Urticaria—Epirubicin—hematologic cancer	1.41e-05	4.72e-05	CcSEcCtD
Imiquimod—Pain—Doxorubicin—hematologic cancer	1.4e-05	4.7e-05	CcSEcCtD
Imiquimod—Body temperature increased—Epirubicin—hematologic cancer	1.4e-05	4.7e-05	CcSEcCtD
Imiquimod—Abdominal pain—Epirubicin—hematologic cancer	1.4e-05	4.7e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—hematologic cancer	1.39e-05	4.68e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—PC—hematologic cancer	1.39e-05	0.000117	CbGpPWpGaD
Imiquimod—Asthenia—Methotrexate—hematologic cancer	1.36e-05	4.55e-05	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—hematologic cancer	1.35e-05	4.53e-05	CcSEcCtD
Imiquimod—Nausea—Prednisone—hematologic cancer	1.34e-05	4.51e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—SLC35B2—hematologic cancer	1.34e-05	0.000113	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GBA—hematologic cancer	1.34e-05	0.000113	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.34e-05	4.49e-05	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—hematologic cancer	1.34e-05	4.49e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Epirubicin—hematologic cancer	1.3e-05	4.38e-05	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—hematologic cancer	1.3e-05	4.37e-05	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—hematologic cancer	1.29e-05	4.34e-05	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—hematologic cancer	1.29e-05	4.34e-05	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—hematologic cancer	1.29e-05	4.34e-05	CcSEcCtD
Imiquimod—CYP3A4—Metabolism—DCK—hematologic cancer	1.29e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.29e-05	0.000108	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ASNS—hematologic cancer	1.29e-05	0.000108	CbGpPWpGaD
Imiquimod—Asthenia—Epirubicin—hematologic cancer	1.27e-05	4.26e-05	CcSEcCtD
Imiquimod—Pruritus—Epirubicin—hematologic cancer	1.25e-05	4.2e-05	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—hematologic cancer	1.25e-05	4.2e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—MTAP—hematologic cancer	1.23e-05	0.000103	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HDC—hematologic cancer	1.22e-05	0.000102	CbGpPWpGaD
Imiquimod—Diarrhoea—Epirubicin—hematologic cancer	1.21e-05	4.06e-05	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—hematologic cancer	1.21e-05	4.05e-05	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—hematologic cancer	1.2e-05	4.04e-05	CcSEcCtD
Imiquimod—Rash—Methotrexate—hematologic cancer	1.19e-05	4e-05	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—hematologic cancer	1.19e-05	4e-05	CcSEcCtD
Imiquimod—Headache—Methotrexate—hematologic cancer	1.18e-05	3.98e-05	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—hematologic cancer	1.17e-05	3.94e-05	CcSEcCtD
Imiquimod—Dizziness—Epirubicin—hematologic cancer	1.17e-05	3.93e-05	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—hematologic cancer	1.16e-05	3.89e-05	CcSEcCtD
Imiquimod—Vomiting—Epirubicin—hematologic cancer	1.12e-05	3.78e-05	CcSEcCtD
Imiquimod—Nausea—Methotrexate—hematologic cancer	1.12e-05	3.77e-05	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—hematologic cancer	1.12e-05	3.76e-05	CcSEcCtD
Imiquimod—Rash—Epirubicin—hematologic cancer	1.12e-05	3.75e-05	CcSEcCtD
Imiquimod—CYP3A4—Metabolism—CDA—hematologic cancer	1.11e-05	9.35e-05	CbGpPWpGaD
Imiquimod—Dermatitis—Epirubicin—hematologic cancer	1.11e-05	3.74e-05	CcSEcCtD
Imiquimod—Headache—Epirubicin—hematologic cancer	1.11e-05	3.72e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—FHL2—hematologic cancer	1.09e-05	9.19e-05	CbGpPWpGaD
Imiquimod—Dizziness—Doxorubicin—hematologic cancer	1.08e-05	3.63e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—AGRN—hematologic cancer	1.07e-05	9.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PC—hematologic cancer	1.07e-05	9e-05	CbGpPWpGaD
Imiquimod—Nausea—Epirubicin—hematologic cancer	1.05e-05	3.53e-05	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—hematologic cancer	1.04e-05	3.49e-05	CcSEcCtD
Imiquimod—CYP3A4—Metabolism—GBA—hematologic cancer	1.04e-05	8.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.04e-05	8.7e-05	CbGpPWpGaD
Imiquimod—Rash—Doxorubicin—hematologic cancer	1.03e-05	3.47e-05	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—hematologic cancer	1.03e-05	3.46e-05	CcSEcCtD
Imiquimod—Headache—Doxorubicin—hematologic cancer	1.03e-05	3.44e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—HMMR—hematologic cancer	1.02e-05	8.54e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH2—hematologic cancer	1.02e-05	8.54e-05	CbGpPWpGaD
Imiquimod—Nausea—Doxorubicin—hematologic cancer	9.72e-06	3.26e-05	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.59e-06	8.05e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ARNTL—hematologic cancer	9.57e-06	8.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTAP—hematologic cancer	9.48e-06	7.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CA9—hematologic cancer	9.31e-06	7.81e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ACP5—hematologic cancer	9.31e-06	7.81e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOR2—hematologic cancer	9.18e-06	7.71e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—IDH1—hematologic cancer	8.75e-06	7.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCC3—hematologic cancer	8.65e-06	7.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TXN—hematologic cancer	8.65e-06	7.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTO1—hematologic cancer	8.65e-06	7.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SPHK1—hematologic cancer	8.47e-06	7.11e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FHL2—hematologic cancer	8.45e-06	7.09e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AGRN—hematologic cancer	8.28e-06	6.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UGT1A1—hematologic cancer	8.13e-06	6.83e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CRABP1—hematologic cancer	7.91e-06	6.64e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SLC22A1—hematologic cancer	7.91e-06	6.64e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH2—hematologic cancer	7.85e-06	6.59e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMMR—hematologic cancer	7.85e-06	6.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALOX5—hematologic cancer	7.71e-06	6.47e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NUP98—hematologic cancer	7.47e-06	6.27e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ARNTL—hematologic cancer	7.38e-06	6.2e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ADCY7—hematologic cancer	7.25e-06	6.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOA3—hematologic cancer	7.25e-06	6.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NUP214—hematologic cancer	7.2e-06	6.04e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ACP5—hematologic cancer	7.18e-06	6.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CA9—hematologic cancer	7.18e-06	6.03e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.12e-06	5.98e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOR2—hematologic cancer	7.09e-06	5.95e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCG2—hematologic cancer	7.05e-06	5.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTR—hematologic cancer	7.05e-06	5.92e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ENO2—hematologic cancer	6.92e-06	5.8e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—IDH1—hematologic cancer	6.75e-06	5.67e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTT1—hematologic cancer	6.71e-06	5.63e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCC3—hematologic cancer	6.68e-06	5.6e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTO1—hematologic cancer	6.68e-06	5.6e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TXN—hematologic cancer	6.68e-06	5.6e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.61e-06	5.54e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—SDC1—hematologic cancer	6.56e-06	5.5e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SPHK1—hematologic cancer	6.53e-06	5.48e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UGT1A1—hematologic cancer	6.28e-06	5.27e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.26e-06	5.26e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.18e-06	5.19e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SLC22A1—hematologic cancer	6.11e-06	5.13e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CRABP1—hematologic cancer	6.11e-06	5.13e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.95e-06	4.99e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.91e-06	4.96e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NUP98—hematologic cancer	5.76e-06	4.84e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ADCY7—hematologic cancer	5.6e-06	4.7e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOA3—hematologic cancer	5.6e-06	4.7e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NQO1—hematologic cancer	5.57e-06	4.68e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CD44—hematologic cancer	5.57e-06	4.68e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NUP214—hematologic cancer	5.56e-06	4.66e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.46e-06	4.58e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCG2—hematologic cancer	5.44e-06	4.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTR—hematologic cancer	5.44e-06	4.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ENO2—hematologic cancer	5.34e-06	4.48e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYCS—hematologic cancer	5.28e-06	4.43e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	5.24e-06	4.4e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTT1—hematologic cancer	5.18e-06	4.35e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SDC1—hematologic cancer	5.06e-06	4.25e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.72e-06	3.96e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—hematologic cancer	4.65e-06	3.9e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.5e-06	3.78e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCB1—hematologic cancer	4.4e-06	3.69e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CD44—hematologic cancer	4.3e-06	3.61e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NQO1—hematologic cancer	4.3e-06	3.61e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—hematologic cancer	4.27e-06	3.59e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NCOR1—hematologic cancer	4.27e-06	3.59e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYCS—hematologic cancer	4.07e-06	3.42e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.05e-06	3.4e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—hematologic cancer	3.78e-06	3.17e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.59e-06	3.01e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.4e-06	2.85e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.33e-06	2.79e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.3e-06	2.77e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.3e-06	2.77e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CG—hematologic cancer	3.17e-06	2.66e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CREBBP—hematologic cancer	2.94e-06	2.47e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.91e-06	2.45e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CD—hematologic cancer	2.79e-06	2.34e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—hematologic cancer	2.75e-06	2.31e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3R1—hematologic cancer	2.63e-06	2.21e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.45e-06	2.06e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CB—hematologic cancer	2.43e-06	2.04e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.27e-06	1.91e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.15e-06	1.81e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—hematologic cancer	2.13e-06	1.78e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—hematologic cancer	2.1e-06	1.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.03e-06	1.71e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—EP300—hematologic cancer	2e-06	1.68e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.88e-06	1.57e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—hematologic cancer	1.62e-06	1.36e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—EP300—hematologic cancer	1.55e-06	1.3e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—hematologic cancer	1.48e-06	1.24e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—hematologic cancer	1.21e-06	1.02e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.14e-06	9.6e-06	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—hematologic cancer	9.34e-07	7.84e-06	CbGpPWpGaD
